Philadelphia chromosome-positive mature B-cell (Burkitt cell) leukaemia

6Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Philadelphia chromosome-positive (Ph+) acute leukaemia usually shows lymphoblastic morphology and a B-precursor phenotype. The bone marrow aspirate of a 9-year-old boy showed a L3 blast cell morphology in 90% of cells; immunophenotyping revealed a mature B-blast population. The translocation t(9;22) (q34;q11) was seen in 45 out of 50 metaphases, and expression of the corresponding bcr1/abl fusion transcripts, but no IgH/myc co-localization or splitting of c-myc, was demonstrated. Chemotherapy according to the Berlin-Frankfurt-Munster non-Hodgkin's lymphoma (NHL-BFM 95) protocol with maintenance according to the BFM acute lymphoblastic leukaemia (ALL-BFM 90) protocol resulted in continuing complete remission of 54 months. The occurrence of Ph+ Burkitt's leukaemia might reflect multiple-step cancer development.

Cite

CITATION STYLE

APA

Mann, G., Trebo, M. M., Haas, O. A., Grümayer-Panzer, E. R., Dworzak, M. N., Lion, T., & Gadner, H. (2002). Philadelphia chromosome-positive mature B-cell (Burkitt cell) leukaemia. British Journal of Haematology, 118(2), 559–562. https://doi.org/10.1046/j.1365-2141.2001.03598.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free